JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
KRNY
Kearny Financial Corp.
KRNY has the edge over JPM overall, supported by stronger valuation.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
KRNY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
KRNY's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like KRNY.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
KRNY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $9.15 | — |
| Cheap | 12x | $6.89 | -25% |
| Fair | 15x | $8.97 | -1.9% |
| Current | 16x | $9.15 | — |
| Expensive | 20x | $11.37 | +24% |
Historical ranges are pointers, not guarantees.
KRNY has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
KRNY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
KRNY has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over KRNY on earnings, with more consistent year-over-year improvement.
KRNY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | +41% |
| Q3 2026 | $0.58 | +23% |
| Q2 2026 | $0.57 | +36% |
| Q1 2026 | $0.57 | +$1.71 |
| Q4 2025 | $0.52 | +$1.65 |
| Q3 2025 | $0.47 | +$1.92 |
| Q2 2025 | $0.42 | +$1.81 |
| Q1 2025 | -$1.14 | -556% |
| Q4 2024 | -$1.13 | -490% |
KRNY's earnings per share have fallen from their peak: $0.58 over the past year, against $1.01 in early 2022.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over KRNY on profitability, with a higher operating margin.
KRNY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $45.3M | +4% |
| Q2 2026 | $45.7M | +12% |
| Q1 2026 | $45.3M | +17% |
| Q4 2025 | $43.5M | +16% |
| Q3 2025 | $43.6M | +17% |
| Q2 2025 | $40.8M | +4.5% |
| Q1 2025 | $38.6M | +0.2% |
| Q4 2024 | $37.5M | +89% |
KRNY has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | +0.5 points |
| Q2 2026 | 24% | +4.1 points |
| Q1 2026 | 28% | +7.6 points |
| Q4 2025 | 27% | +6.2 points |
| Q3 2025 | 27% | +8.1 points |
| Q2 2025 | 20% | +253 points |
| Q1 2025 | 20% | -3.3 points |
| Q4 2024 | 21% | +82 points |
KRNY's operating margin was 28% last quarter, about level with the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
KRNY has the stronger cash trend. Its trailing FCF is down 37% versus its history, compared with JPM at down 229%.
KRNY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.3M | +520% |
| Q1 2026 | $7.9M | -53% |
| Q4 2025 | $14.3M | +$17M |
| Q3 2025 | $1.5M | -41% |
| Q1 2025 | $16.8M | -4.4% |
| Q4 2024 | -$2.7M | -139% |
| Q3 2024 | $2.5M | -79% |
| Q1 2024 | $17.6M | -17% |
KRNY's free cash flow was $33M over the past year, down 3.4% from the year before. Free cash flow isn't a meaningful measure for financial services companies like KRNY.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over KRNY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
KRNY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +343K shares |
| 1 year | +1% | +612K shares |
| 3 years | +0.8% | +502K shares |
| 5 years | -15% | -11M shares |
| Available history | -23% | -19.3M shares |
KRNY has 64M diluted shares, up 1% from a year ago.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
KRNY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 14.7x | High |
| Q3 2025 | 21.6x | High |
| Q2 2025 | 26.2x | High |
| Q1 2024 | 44.6x | High |
| Q4 2023 | 85.3x | High |
| Q3 2023 | 60.8x | High |
| Q2 2023 | 46.3x | High |
| Q1 2023 | 43.6x | High |
KRNY's net debt is about 15 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like KRNY.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
KRNY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.2 | Neutral |
| Stochastic | 19.3 | Oversold |
KRNY's weekly RSI is 52 (neutral) and its Stochastic is 19 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over KRNY on valuation relative to its sector.
KRNY PE vs Financial Services Sector
| Metric | KRNY | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 21% above |
| PE % | 55 | 63 | 8 pts below |
KRNY is trading at 16x earnings, a 21% premium to the Financial Services sector's median of 13x.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over KRNY on trend strength, trading above more of its moving averages.
KRNY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.16 | 0.1% below |
| 20 week MA | $9.43 | 3% below |
| 50 week MA | $8.52 | 7.4% above |
| 100 week MA | $7.51 | 22% above |
| 200 week MA | $7.43 | 23% above |
KRNY has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 23% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
KRNY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.8 | $10.6 | -23% |
| 2021 | $10.6 | $13.1 | +24% |
| 2022 | $13.1 | $10.3 | -21% |
| 2023 | $10.3 | $8.97 | -13% |
| 2024 | $8.97 | $7.07 | -21% |
| 2025 | $7.07 | $7.58 | +7.2% |
| 2026 YTD | $7.58 | $9.15 | +21% |
KRNY has the edge over JPM on returns for 2026, with the stronger performance.